Literature DB >> 16005368

Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.

Hahn Wook Kang1, Dong Joon Kim, Myung-Shik Lee, Kwang-Won Kim, Moon-Kyu Lee.   

Abstract

OBJECTIVE: To investigate the clinical characteristics and predisposing metabolic abnormalities in the development of glucose intolerance and diabetes mellitus in obese and non-obese Korean subjects.
METHODS: Four hundred Korean subjects were classified into five groups according to degree of glucose tolerance by OGTT: NGT, IGT alone, IFG alone, IFG+IGT, and DM. The groups were also subdivided into obese and non-obese group according to body mass index. Insulin resistance was assessed by using homeostasis model assessment of insulin resistance (HOMA-R), and insulinogenic index was used as an index of early-phase insulin secretion.
RESULTS: Impaired early-phase insulin secretion was seen in non-obese IGT alone, IFG alone, and IFG+IGT, though more profound secretory defects were noted in IFG+IGT and DM. No significant difference were found in HOMA-R among non-obese IGT alone, IFG alone, or IFG+IGT, or in terms of early-phase insulin secretion in obese IGT alone, IFG alone, or IFG+IGT. However, the magnitude of insulin resistance differed in the obese group, IFG+IGT and DM being more insulin resistant than IGT alone or IFG alone.
CONCLUSIONS: These results suggest that the predisposing metabolic abnormality in non-obese subjects with IGT alone or IFG alone and in progression to IFG+IGT might be deterioration of early phase insulin secretion, whereas insulin resistance might be the major contributory factor in obese subjects. The predisposing metabolic abnormality leading to diabetes in both obese and non-obese groups was deterioration of early-phase insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005368     DOI: 10.1016/j.diabres.2004.12.011

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  4 in total

1.  Efficacy and safety of vildagliptin/pioglitazone combination therapy in Korean patients with diabetes.

Authors:  Sun-Woo Kim; Sei Hyun Baik; Kun Ho Yoon; Hyoung Woo Lee; Claudia Filozof
Journal:  World J Diabetes       Date:  2010-11-15

2.  Adolescent build plotting on body composition chart and the type of diabetes mellitus.

Authors:  Hye Won Park; Yong Hyuk Kim; Myunghyun Cho; Byung Ok Kwak; Kyo Sun Kim; Sochung Chung
Journal:  J Korean Med Sci       Date:  2012-10-30       Impact factor: 2.153

3.  Influence of gastrectomy for stomach cancer on type 2 diabetes mellitus for patients with a body mass index less than 30 kg/m(2).

Authors:  Kyu Chul Kang; Seok Hwan Shin; Yeon Ji Lee; Yoon Seok Heo
Journal:  J Korean Surg Soc       Date:  2012-05-29

4.  Risk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.

Authors:  Anne Neumann; Margareta Norberg; Olaf Schoffer; Fredrik Norström; Ingegerd Johansson; Stefanie J Klug; Lars Lindholm
Journal:  BMC Public Health       Date:  2013-10-26       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.